Rift Valley fever virus (RVFV) infections in pregnant livestock are associated with high 15 rates of fetal demise and have been linked to miscarriage in pregnant women. To address how 16 acute RVFV infection during pregnancy causes detrimental effects on the fetus, we developed an 17 immunocompetent pregnant rodent model of RVFV infection. We found that pregnant rats were 18 more susceptible to RVFV-induced death than their non-pregnant counterparts and that RVFV 19 infection resulted in intrauterine fetal death and severe congenital abnormalities, even in pups from 20 infected asymptomatic pregnant rats. Virus distribution in infected dams was widespread, with a 21 previously unrecognized preference for infection, replication, and tissue damage in the placenta. 22
Introduction 29
Rift Valley fever (RVF) is a veterinary disease of domesticated livestock that is frequently 30 transmitted to humans. RVF virus (RVFV; Phenuiviridae; formerly Bunyaviridae) is currently 31 endemic in many regions of Africa and is transmitted by a range of mosquito species (1) (2) (3) (4) . 32
Prominent instances of emergence of RVFV in new areas (such as Egypt in 1977-78 and Saudi 33
Arabia in 2000-01) have caused concern for further spread given that mosquito species found in 34 Europe and the Americas could potentially harbor and transmit RVFV (5-7). The World Health 35
Organization warns of a pending public health emergency caused by RVF due to insufficient 36 vaccines and therapeutics (8) . 37
Epizootic outbreaks of RVF predominantly affect young ruminants such as sheep, goats, 38 cattle, and camels. Within a given outbreak, infected animals succumb to disease characterized by 39 fulminant hepatic necrosis (9) . The most notable and economically devastating outcome of RVF 40 is the "abortion storm" that sweeps through herds of pregnant livestock, with abortogenic rates 41 reaching as high as 90-100% in pregnant ewes (10, 11) . Even live-attenuated veterinary vaccines 42 induce abortions in pregnant animals and cause physical abnormalities in fetuses and newborns 43 (12).
44
In humans, RVF disease is primarily an acute febrile illness accompanied by body aches 45 and joint pain, with occasional progression to more severe systemic disease. Data from human 46 outbreaks, while limited, suggest that vertical transmission of RVFV to the developing human 47 fetus can occur with detrimental outcomes. Two published cases of vertical transmission resulted 48 temperature transponders (IPTT-300; Bio Medic Data Systems) subcutaneously between the 116 shoulder blades. For infection, all rats were anesthetized by inhalation of isoflurane vapors 117 (IsoThesia, Henry Schein) and inoculated subcutaneously in the hind flank with 500 µL of RVFV 118 diluted in D2 media. Weight and body temperature were recorded daily starting the day of 119 infection. Additionally, each animal was closely monitored twice daily for the development of 120 clinical signs. Endpoint criteria, which prompts immediate euthanasia, was defined based on 121 weight, temperature, appearance, and behavioral scoring parameters. Once euthanasia criteria were 122 met, rats were anesthetized by inhalation of isoflurane vapors followed by an immediate blood 123 draw and euthanasia by cardiac puncture. 124
Rats were inoculated on E14 with the following doses of RVFV strain ZH501: 7.5 x 10 1 125 pfu (n=5), 1.8 x 10 2 pfu (n=6), 1.5 x 10 3 pfu (n=11) and 2.6 x 10 4 pfu (n=6). Unless dams met 126 euthanasia criteria, they progressed to full-term and delivered pups on E22 (8 dpi). After delivery, 127 dams and pups were not disturbed until 5 days post-delivery (13 dpi) to reduce stress. Added stress 128 on the dams can lead to consumption of newborn pups by dam (17, 18) . Weight monitoring of pups 129 began on neonatal day 5 (13 dpi) until 18 dpi when both dam and pups were euthanized at the pre-130 rats met euthanasia criteria and were euthanized, the rats were euthanized at a pre-determined end 137 date of the study at 16 dpi. 138
Upon necropsy, tissues were harvested and suspended in 2x weight/volume D2 media and 139 homogenized using an Omni tissue homogenizer (Omni International). Tissue homogenates were 140 used to quantitate infectious virus by VPA inside of the BSL-3 facility. For quantitation of RVFV-141 specific viral RNA by q-RT-PCR analysis, 100 µL of each tissue homogenate was inactivated in 142 900 µL Tri-Reagent (Invitrogen) for ten minutes prior to removal from the BSL-3 facility. 143
Subsequent storage at -80°C or RNA isolation and q-RT-PCR analyses occurred in a BSL-2 144 setting. 145
RNA isolation and q-RT-PCR 146
RNA isolation was performed using a modified Invitrogen PureLink Viral RNA/DNA kit 147 protocol. Briefly, 200 µL of chloroform was added to the tissue homogenate/Tri-Reagent, mixed, 148 then centrifuged at 4°C at 12,000 x g for 15 minutes to separate the organic phase from the aqueous 149 phase (contains RNA). The aqueous phase of the cell lysates was collected then mixed with an 150 equal volume of 70% ethanol, then the sample was applied to the PureLink spin column. The 151
PureLink Viral RNA/DNA kit protocol, including DNase treatment, was followed for the 152 remainder of RNA isolation procedure. q-RT-PCR was performed using the SuperScript III 153
Platinum One-Step q-RT-PCR Kit (Invitrogen) following the manufacturer's guidelines. Primers 154 targeting the RVFV L segment include: RVFV-2912Fwd 5' TGAAAATTCCTGAGACACATGG 155 3' and RVFV-2912Rev 5' ACTTCCTTGCATCATCTGATG 3'. Taqman probe (RVFV-2950 156
Probe 5' CAATGTAA GGGGCCTGTGTGGACTTGTG 3') were labeled at the 5'-end with the 157 reporter molecule 6-carboxyfluorescein (6-FAM) and quenched internally at a modified "T" 158 residue with BHQ1 (Black Hole Quencher), with a modified 3'end to prevent probe extension by 159
Taq polymerase (19 Amnion (fetal membrane), decidua (maternal tissue), and chorionic villi were separated 171 from whole placental tissue and cut to 1 cm x 1 cm sections. Each tissue section was placed in a 172 well of a 24-well plate (Corning) and inoculated with the following doses of RVFV strain ZH501, 173 in duplicate: 1.6 x 10 7 pfu (n=2 per donor), 3.0 x 10 6 pfu, 3.0 x 10 5 pfu, 3.0 x 10 4 pfu, or 3.0 x 10 174 3 pfu (n=4 per donor unless otherwise stated). Five hundred microliters of virus diluted in D2 media 175 was added to each tissue and incubated in a 37°C incubator for 1 hour for viral adsorption. The 176 inoculum was removed, washed twice with PBS, then replaced with 1 mL of complete growth 177 media (DMEM/F12, 10% FBS, 1% penicillin-streptomycin, amphotericin B). To generate a viral 178 growth curve, 50 µL was collected from each tissue every twelve hours for forty-eight hours and 179 analyzed by q-RT-PCR. Forty-eight hours post-infection, all supernatant was collected, and tissues 180 were washed two times with PBS then fixed in 4% PFA for 24 hours for fluorescent microscopy 181 imaging. Tissues or supernatant were analyzed in quadruplets; two of these tissues were processed 182 for fluorescent microscopy. 183
Fluorescent Microscopy 184
Human tissue was fixed in 4% paraformaldehyde (PFA) for 24 hours at 4 o C, washed in 1x 185 PBS, and then permeabilized with 0.25% Triton X-100 in 1x PBS for 30 minutes at room 186 temperature with gentle agitation. Tissue was washed and then incubated with antibodies to double 187 stranded RNA (recombinant J2, as described previously (20) For fixation of tissues and inactivation of virus, tissues were submerged for 24 hours in 4% 200 paraformaldehyde (PFA) at 4°C. Prior to removal from the BSL-3 laboratory, the 4% PFA was 201 replaced with fresh 4% PFA. In the BSL-2 laboratory, 4% PFA was removed and washed from 202 tissue with 1x PBS then submerged in PBS and stored at 4°C until processed further. Tissues were 203 paraffin embedded and sections were cut onto slides following standard histological processes by 204 the University of Pittsburgh McGowan Institute Histology Core. 205
Whole pups were submerged in 4% PFA for 24 hours. To ensure complete inactivation, 206 pups were cut in half laterally, then exposed to 4% PFA for another 24 hours prior to removal from 207 the BSL-3 laboratory. Half pups were further cut into whole head and abdomen sections in the 208 BSL-2 laboratory prior to embedding in paraffin and cut onto slides. 209
Slides were deparaffinized using an alcohol rehydration series then stained following 210 standard hematoxylin and eosin staining procedures. For immunohistochemistry, fixed slides were 211 deparaffinized using an alcohol rehydration series and boiled in 10mM citric acid buffer pH 6.0 to 212 unmask antigen binding epitopes. Primary antibody was IBT Bioservices Rift Valley Fever MP12 213 Antibody (Catalog# 04-001); secondary antibody was Vector Laboratories Biotinylated Horse 214
Anti-Rabbit (H+L) (Catalog# BA-1000). Chromogen staining for visualization was carried out 215 using the Vector Laboratories Vector Blue Alkaline Phosphatase Substrate kit according to 216 manufacturer's instructions. Slides were imaged using the Nikon 90i Eclipse epifluorescent 217 microscope provided by the University of Pittsburgh Center for Biologic Imaging. 218
Statistics 219
Statistical analysis was performed using Graphpad Prism 7.0. Survival of pup and dams 220 was compared using Mann Whitney-U test. Growth curve of pups 7 and 8 from dam 4 was 221 calculated using linear regression modeling. Intensity of RVFV immunostaining in uninfected and 222 infected human placental tissue was compared using a t-test. 223
Results 224

Susceptibility of late-gestation pregnant Sprague-Dawley rats to RVFV disease and death 225
Rats develop severe disease after RVFV infection, similar to that observed in domesticated 226 livestock and humans (21, 22) . We have previously used rats to study different disease outcomes 227 resulting from RVFV infection (21, 23) . Although there are significant morphologic differences 228 between the placentas of humans and rodents, rats are often used to study placental development, 229 embryogenesis, embryotoxicity, and vaccine teratogenicity during pregnancy (24-29). The fully 230 intact placenta forms a physical barrier between the mother and fetus, facilitates nutrient exchange, 231 and protects the developing fetus from microbial invasion. The gestational period for rats is 22 232 days, and by embryonic day 14 (E14), the placenta is fully formed with deep trophoblast invasion 233 within the uterine wall (24) . 234
For these studies, time-mated Sprague-Dawley (SD) rats at E14 were infected with the 235 pathogenic ZH501 strain of RVFV by subcutaneous injection (s.c.) in the hind flank ( Fig. 1A ). As 236 controls, age-matched, non-pregnant rats were similarly infected. Some rats developed severe 237 disease as a result of infection, and in these cases, euthanasia endpoint criteria were met within 2-238 6 days after infection in both pregnant and non-pregnant groups (Fig. 1B ). Rats that survived 239 infection had few signs of disease and delivered pups on E22. Surviving pups were not handled 240 until 5 days after delivery, after which they were weighed daily. Surviving dams and pups were 241 euthanized at the end of the study (neonatal age of 10 days; 18 days post-infection (dpi)) ( Fig. 1A) . 242
The pregnant rats were more susceptible to death after infection than their non-pregnant 243 counterparts ( Fig. 1B) . Non-pregnant rats survived infection despite exposure to high doses of 244 RVFV (only 2 out of 22 died; 9%), whereas 57% of pregnant rats died (16 out of 28) when exposed 245 to even low doses of RVFV (p = 0.0008). Within the pregnant rat cohort, there was no association 246 between death after infection and the administered dose (p = 0.321). 247
Reproductive tissues are targets of RVFV infection in pregnant and non-pregnant rats 248
The distribution of virus throughout the tissues was measured by q-RT-PCR and/or viral 249 plaque assay (VPA) in pregnant rats that succumbed to lethal disease (2-6 dpi) ( Fig. 1C ), pregnant 250 rats that survived (18 dpi; Fig. 1D ), and their non-pregnant counterparts (16 dpi for survivors; 251
Suppl. Fig. 1A-B ). Infectious virus was widely distributed throughout the animals that succumbed, 252 regardless of pregnancy status. In surviving animals at 18 dpi, infectious viral burden was 253 significantly reduced in both pregnant and non-pregnant rats (data not shown). Viral RNA, 254 however, remained widely distributed in the survivors at the end of the study, 18 dpi ( Fig. 1D ). As Placental samples were available from the pregnant rats that succumbed to disease and a 260 few that survived (most surviving rats consumed the placenta at the time of delivery and were not 261 available for analysis) (Fig. 1E ). The placenta contained high levels of infectious virus measured 262 by plaque assay regardless of the time post-infection. Even the placentas obtained from the 263 surviving rats on the day of delivery contained extraordinary amounts of infectious virus, with one 264 animal having over 10 9 pfu/ml. 265
In addition to the placenta, the uterus, ovary, and amniotic sac contained infectious virus 266 in the lethally-infected rats (Fig. 1C) , and viral RNA persisted in these tissues in survivors ( Fig.  267 1D). Virus was also found in the mammary glands (4/5 rats had detectable vRNA; 1 had infectious 268 virus), indicating vertical transmission of RVFV from dam to pup could possibly occur through 269 lactation. There is indeed a concern that consumption of raw milk from goats and cattle may be a 270 risk for human infection with RVFV (30). 271
Compared to controls, histology sections of livers from lethally-infected pregnant (Fig. 2 ) 272 and non-pregnant (Suppl. Fig. 1C ) rats displayed a reproducible pattern of tissue injury that 273 included widespread sinusoidal congestion, multifocal recent hemorrhage, massive hepatocyte 274 necrosis, and acute inflammation. These are classic histological findings in animals infected with 275 RVFV (31). In addition, the livers of infected rats had high levels of RVFV-antigen (Suppl. Fig.  276 1 D-E). Altogether, our data suggest that both pregnant and non-pregnant rats succumb to 277 infection following massive liver necrosis, although pregnant rats are more susceptible to 278 developing disease after exposure to low levels of virus compared to non-pregnant rats (Fig. 1B) . 279
The placentas from lethally and sub-lethally infected dams displayed a reproducible pattern 280 of tissue injury that included multifocal necrosis and recent hemorrhage in the decidua and 281 trophospongiosum; vascular congestion and massive necrosis of parenchymal cells within the 282 labyrinth; and an acute intravascular and perivascular inflammatory infiltrate associated with 283 intraplacental arteries (Fig 2A,B) . Also seen was a discernable increase in circulating nucleated 284 red blood cells (nRBCs). 285
Within lethally-infected dams, necrotic lesions were found within the uterus ( Fig. 2A) . 286
Several pregnant dams that survived infection had subserosal nodules within the myometrium of 287 the uterus that showed evidence of liquefactive necrosis, acute inflammation, and calcification. 288
Despite the presence of viral RNA and infectious RVFV within the ovaries of both non-pregnant 289 (Suppl. Fig. 1A -B) and pregnant ( Fig. 1C -D) RVFV-infected rats, reproducible histopathological 290 changes were not observed. 291
RVFV vRNA was also found in the testes of infected male Lewis rats (Sup. Fig. 2 ). The 292 levels of RVFV viral RNA and infectious particles found here in the uterus, ovary, placenta, 293 amniotic sac, mammary glands, and testes, as well as the histological damage in certain tissues, 294
demonstrates that RVFV has a previously unappreciated preference for targeting the reproductive 295
tissues. 296
Direct vertical transmission of RVFV to pups during late-gestation results in pup deformity and 297 demise 298
Within the pregnant dams that succumbed to RVFV infection at 2-6 dpi, virus was 299 widespread throughout various tissues, corroborating the pantropic nature of RVFV (Fig. 1C) . 300
Within the corresponding pups from these dams that died, q-RT-PCR of the peritoneal cavity or 301 brains also detected high levels of viral RNA (Fig. 3A ). Vertical transmission occurred while the 302 pups were in utero, as the dams were euthanized prior to delivery. 303
Because most humans develop non-lethal febrile illness when infected with RVFV, we 304 were interested in the outcome of the pups from dams that survived infection with few to no clinical 305 signs. Remarkably, many of the pups born from these surviving, clinically-normal dams were dead 306 at delivery or shortly thereafter ( Fig. 3B ). Of ten pregnant dams that survived infection and reached 307 full-term (E22), all gave birth to at least one pup that died either due to infection or consumption 308 on the days following delivery. An additional dam survived to full-term; however, all pups were 309 consumed by this dam and were unable to be recorded for analysis. 310
The eleven infected dams gave birth to a total of 111 pups, 39 of which survived (35.1%). 311
In comparison, of the eight uninfected control dams, 66 of 88 (75.0%) pups survived to the end of 312 the study (p < 0.0001). Dams are known to eat their young due to stress (such as the laboratorian 313 disturbing the pups to weigh them after delivery) or if they notice abnormalities (17, 18) . Some of 314 the uninfected dams consumed their pups during this study, so the survival rate of the pups from 315 uninfected dams can be considered the baseline for these experimental conditions. The average 316 survival rate of pups per litter delivered by infected dams was 27.2%, whereas uninfected rats were 317 2.45-times more likely to survive (66.8%; p = 0.02). Outcomes from 4 specific dam cases are 318 presented and discussed in the following section. 319
Overall, we detected very high levels of viral RNA (10 6 -10 7 pfu/mL eq.) in the peritoneal 320 cavity of still-born pups birthed by dams that had no apparent clinical disease ( Fig. 3B ). It is quite 321 striking that the virus was vertically transmitted and replicated to high levels in the pups, while 322 causing no clinical disease in the dam herself. Viral RNA was also detected in the brains of pups 323 from both surviving and lethally-infected dams (Fig. 3A,B ). Fetal resorption is characteristic of 324 vertical transmission in animals infected with viruses such as Zika virus (32) and vesicular 325 stomatitis virus (33). Evidence of fetal resorption occurred in three lethally-infected dams exposed 326 to RVFV during late-stage gestation ( Fig. 3C & Suppl. Fig. 3 ). 327 H&E sections of whole pups from lethally-infected dams showed significant liver damage 328 (massive parenchymal necrosis, vascular congestion and areas of recent hemorrhage) ( Fig. 3D ). 329
Pups also displayed altered intestinal structure compared to pups from uninfected dams. 330
During the late stages of pregnancy, RVFV is directly transmitted to the developing pups 331 resulting in increased rates of death and tissue damage. Interestingly, this is not an all-or-nothing 332 phenomenon within individual litters, as we found that physiological changes and survival varied 333 within the same litter. To illustrate this, four selected cases are described below. 334
Description of individual dam cases 335
Dam 1 reached full-term gestation with no apparent clinical signs nor significant liver 336 damage, yet she still died giving birth (8 dpi). Dam 1 delivered eleven pups that were all dead upon 337 delivery, with 2 pups remaining within the uterus at the time of her demise (Fig. 4A ). Like other 338 RVFV-infected dams, viral RNA was widespread throughout the dam's tissues ( Fig. 4B ). Because 339 this dam died during delivery, the placenta was available to directly compare the virus burden of 340 the placenta to other maternal tissues harvested at the same time. In the other cases discussed 341 below, the dams ate placentas after birth, so they were unavailable to sample. Strikingly, at the 342 time of death, dam 1 had 10 7 pfu/mL of virus in the placenta, which is 4-logs more viral RNA than 343 the liver and spleen, the primary targets of the virus (Fig. 4B ). In addition, the uterus and ovary 344 had about 1-log more viral RNA than the liver and spleen, demonstrating a preference for RVFV 345 to replicate within reproductive tissues. 346
The stillborn pups from dam 1 had apparent gross abnormalities (small, rounded head and 347 grey discoloration) and variable size (1.5 -3 cm) compared to uninfected pups (5 cm; Fig. 4A ). 348
Nine of the eleven pups (82%) had abnormally shaped heads compared to uninfected pups. Pup 6 349 and 7 likely died earlier in utero, as indicated by their small size and apparent decomposition; both 350 of their heads were disproportionately large due to early gestational demise. While the other pups 351 were larger than pups 6 and 7, none of them were normal in size, and they were all born deceased. 352
The pups had very high levels of viral RNA (10 6 -10 7 pfu/mL eq., irrespective of pup size; were observed in three of the seven pups (pups 2, 3, and 5). Despite pup 1 having similar 365 physiological features and length as a normal pup delivered from an uninfected mother (Fig. 4E) , 366 viral RNA and infectious virus was highest in this pup compared to its littermates that had more 367 severe gross anatomical abnormalities (Figs. 4G-H). This may be due to more advanced 368 decomposition setting in pups 2, 3, and 5 that affected virus infectivity. 369
In another case, dam 3 also survived infection with no clinical signs of disease and had 370 widespread viral RNA in tissues at 18 dpi (Fig. 5B ). She delivered ten pups at full-term (E22); six 371 pups were born deceased and four were alive. Two of the living pups survived until the scheduled 372 euthanasia date (18 dpi; 10 days neonate), whereas the other two were consumed by the dam within 373 two days post-delivery. Pups 1 and 2 from dam 3 were relatively normal in appearance; however 374 they were born deceased and displayed the highest viral RNA (Fig. 5C ) and infectious virus ( Fig.  375 5D) burden compared to littermates with physiological abnormalities; this could be due to the more 376 recent demise of pups 1 and 2 which preserved infectious virus until tissue was collected. The pups 377 who die earlier in utero likely have less infectious virus due to decomposition which affects virus 378 viability. Despite pups 7 and 8 surviving until planned euthanasia at neonatal age of 10 days with 379 no signs of disease or gross abnormalities, viral RNA was still detected in the peritoneal cavity of 380 these pups, although infectious virus was not found (Figs. 5C-D). Pup 7 weighed significantly less 381 than its littermate, and both had similar growth rates (slope = 1.88 for pup 7 and 2.26 for pup 8; p 382 = 0.14) after birth Fig. 5E ). It is unclear if this is natural variation in pup size or an effect of viral 383 infection in utero. 384
Finally, dam 4 had no signs of clinical disease and delivered a total of nine deceased pups 385 at full-term ( Fig. 5F ). Multiple pups were found encapsulated in an amniotic sac and/or still 386 connected to a placenta (Fig. 5J) . Placenta collected the day of delivery had high levels of viral 387 RNA (10 5 pfu/ml eq.); the viral RNA levels in the placenta were similar to that found in the pups, 388 regardless of pup size (Figs. 4H,I) . Seven out of nine pups (78%) had abnormally shaped heads 389 compared to uninfected pups. The pups had gross abnormalities and varied in color from pink to 390 gray to black. Infectious virus was detected in five out of nine pups (Fig. 4I ). The smallest pup 391 (pup 11), measured at about 2.2 cm, while the largest pup from the litter was about 4.1 cm in 392 length; all pups from this litter were still smaller than pups delivered from uninfected dams 393 (typically 5 cm). 394
The four dams highlighted above, despite being asymptomatic, all had liquefactive 395 myonecrosis within the uterus (Fig. 2) . The placenta also had striking abnormalities, including 396 inflammation, cell necrosis, and hemorrhage in the decidua and villous structures (Fig 2A-B) . 397
Vertical transmission of RVFV in an early-gestation pregnant rat 398
To examine the potential for vertical transmission of RVFV prior to the development of a 399 fully formed placenta, an early-gestation (E5) Sprague Dawley dam was infected with 1.5 x 10 5 400 pfu of RVFV along with an uninfected, age-matched, pregnant dam as a control. At seven days 401 post-infection, corresponding to E13, neither dam had clinical signs of disease and both dams 402 underwent planned euthanasia (Suppl. Fig. 4A ). The observed virus distribution in the early-403 gestation pregnant rat resembled that of the late-gestation pregnant rats (Suppl Fig. 4B and Fig. 1 ). 404
Infectious virus was detected in the cervical lymph node, spleen, liver and placenta, with the 405 placenta containing 3-logs more infectious virus than the spleen (10 6 vs 10 3 pfu/mL, respectively; 406
Suppl. Fig. 4B ). Due to the small size of each embryo at this gestational age, embryonic tissue 407 from the entire litter was pooled and analyzed for the presence of viral RNA and infectious 408 particles (Suppl. Fig. 4C ). Pooled embryos had 2-log more viral RNA and infectious virus than the 409 spleen of the dam (10 6.5 vs 10 3 pfu/mL respectively). 410
At the time of euthanasia, the uninfected dam had a healthy uterus containing fourteen 411 embryos, all with similar sizes, shapes, and a translucent, pale-yellow coloring. Of the sixteen 412 embryos of the infected dam, four (25%) were red in color (Suppl. Fig. 4D ) instead of the pale-413 yellow coloring observed in the remaining twelve embryos and embryos of the uninfected control 414 (Suppl. Fig. 4D, left) . Three embryos were smaller than the embryos from the rest of the litter. 415
They lacked amniotic fluid and were palpably dense and hard in appearance (Suppl Fig. 4D ; 416 embryos 4-6); embryos 4 and 5 were two of the four red in color. The red coloring and rigid 417 appearance and structure of embryos from infected dams suggests early hemorrhaging and/or 418 resorption of the embryos. These results show that RVFV is vertically transmitted to embryos of 419 dams infected during early-gestation, with a preferential niche within the placental tissue. 420
Replication of RVFV in human placental tissue 421
Although two isolated cases of vertical transmission have been reported in humans from 422
Africa and the Middle East (13, 14) and a single study highlighted the potential of RVFV-infected 423 women to be 4-times more likely to have a late miscarriage or stillbirth (15), the effect of RVFV 424 infection on the developing human fetus is not known. To evaluate whether human fetal tissue is 425 permissive to RVFV infection and replication, placental chorionic villi were obtained from healthy 426 human donors undergoing elective termination at 16-23 weeks of gestation (second trimester). 427
Tissues were inoculated in vitro with RVFV, and explant supernatant was collected every 12 hours 428 for measurement of viral replication. Similar viral growth kinetics was seen in chorionic villi from 429 2 different donors (Fig. 6A) ; 2-3 log increase in virus production was detected between 12 and 36 430 hours post-infection. 431
To identify the cell type(s) targeted by RVFV in placental villi, we performed 432 immunostaining for double-stranded RNA as described (20) . Viral replication, as assessed by the 433 production of dsRNA, was evident in the villi, with replication observed in both the syncytial layer 434 and the subsyncitial layers within mononuclear cytotrophoblasts (Fig. 6B ). Significantly higher 435 levels of dsRNA signal was detected in infected villi from four different donors compared to 436 uninfected villi from the same donors (Fig. 6C) . These data suggest that RVFV exhibits tropism 437 for human placental tissue and can replicate to some degree in syncytiotrophoblasts which are 438 known to resist many viruses (34) . 439
Discussion 440
Viral infections in pregnant women can have adverse effects on both the mother and the 441 developing fetus. Pregnant women are likely to have more severe pathology, more serious 442 complications, and an increased risk of death compared to non-pregnant women (35, 36) . For both 443 seasonal and pandemic influenza, pregnant women are more susceptible to developing severe 444 complications requiring hospitalization (37, 38) . Other emerging viruses, like Ebola and Lassa, are 445 also more severe or deadly in pregnant women (39, 40) . Here, we found pregnant rats to be more 446 susceptible to severe disease and death after RVFV infection than their non-pregnant counterparts. 447
Necrosis of the liver was characteristic of disease in both pregnant and non-pregnant rats, 448
indicating that pregnancy did not alter the disease presentation, but rather made the pregnant 449 animals more susceptible to severe disease overall. 450
A 1987 study of pregnant women in Mozambique showed that women with miscarriage or 451 stillbirth had the same prevalence of RVFV-specific IgG antibodies as women with normal 452 deliveries (41). However, detection of IgG antibodies is indicative of past exposure to RVFV and 453 not necessarily acute infection during pregnancy. In a more recent cross-sectional study in Sudan, 454 there was a significant association between acute RVFV infection during pregnancy and 455 miscarriage (15). Of the women with confirmed RVFV infections and disease during pregnancy, 456 54% had miscarriage compared to 12% in uninfected women. Acute RVFV infection was an 457 independent predictor of miscarriage (odds ratio of 7.4); all of these miscarriages occurred in the 458 2 nd and 3 rd trimesters (15). While this is only one study, it strongly implicates RVFV infection as 459 a causative agent of miscarriage in late-gestation. Miscarriage earlier in pregnancy due to RVF 460 may also occur but remain underreported. 461
Two cases of vertical transmission of RVFV were documented in Saudi Arabia (2000) and 462
Sudan (2007) (13, 14) . In both cases, onset of RVF-like illness in the mothers occurred around 37-463 38 weeks of gestation. In the two weeks prior to illness in the Saudi woman, 6 family members 464 developed RVF-like illness and 1 died of confirmed RVF. The woman developed RVF-like 465 symptoms 4 days prior to delivery of a full-term infant at home. On the second day of life, the 466 infant was hospitalized with respiratory distress, jaundice, and lethargy. He died 6 days after 467 admission with hemorrhagic signs and an enlarged liver. In the Sudanese patient, labor 468 commenced within 10 days of illness onset, and an infant was born with skin rash, palpable liver 469 and spleen, and an Apgar score of 5. Samples from the mother and cord blood tested positive for 470 RVFV IgM. The outcome of this infant is not known. Taken together, these data suggest that acute 471 RVFV infection is associated with adverse pregnancy outcomes, specifically vertical transmission 472 during the second and third trimesters. 473
To our knowledge, this is the first study to discover the degree to which RVFV targets 474 reproductive tissues and causes catastrophic pathology. The ovaries, uterus, and placenta are 475 previously unrecognized sites of virus replication in both pregnant and non-pregnant 476 immunocompetent animals. A previous study in mice found virus-infected macrophages within 477 the stroma of ovaries from immunodeficient animals infected with an attenuated strain of RVFV 478 (42). Here, we not only found high levels of infectious virus and viral RNA in the reproductive 479 tissues, but the placenta and uterus displayed histologic changes associated with viral infection. 480
Liquefactive necrosis within the uterus of the four dams profiled was striking. Uterine cell death 481 may be a contributing factor to premature placental detachment and intrauterine fetal death within 482 RVFV infected dams. Additionally, the tissues with the highest viral burden were the liver and 483 placenta of lethally and sub lethally-infected pregnant dams. Similarities in physiological functions 484 of these two organs and the high viral load and pathology (massive vascular congestion, recent 485 hemorrhage, cell necrosis, and acute inflammation) observed during infection suggest similar 486 mechanism of disease and infection. Further studies should be performed to understand the onset 487 and progression to fetal demise and elucidate commonalities between the liver and placental 488 structure that accommodates comparable pathology after RVFV infection. 489
The most alarming and arresting finding from our study was the delivery of dead pups from 490 dams that survived RVFV infection, appeared otherwise clinically normal, and gave birth at 491 normal gestation length. The pups displayed physical abnormalities that resembled hydrops fetalis, 492 which is an abnormal accumulation of fluid in the fetus. Hydrops fetalis is seen in RVFV-infected 493 livestock (43) and has been noted as a prominent occurrence in pregnant women infected with 494 parvovirus and Zika (44) (45) (46) (47) . Most humans infected with RVFV develop mild febrile disease, and 495
our study suggests that mild infection of pregnant women may still have devastating impacts on 496 the developing fetus. 497
The data presented also demonstrates the heterogeneous survival and physiological 498 outcomes of pups delivered by RVFV-infected dams. Some dams gave birth to both live and dead 499 pups, and within the dams that delivered only dead pups, there was variation in the size and gross 500 abnormalities seen within pups from the same litter, indicating that infection, growth restriction, 501 developmental abnormalities, and/or death did not occur simultaneously or with the same outcome. 502
Further studies will determine the specific developmental effects that RVFV infection in utero has 503 on the developing fetus. 504
Our work in pregnant rats pointed to the severe teratogenic effects of RVFV. However, 505
given that the human and rodent placenta differ at both the morphologic and cellular levels, which 506 may influence vertical transmission, we also performed studies in human tissue isolated from mid-507 gestation. Importantly, this gestational age represents a stage in which RVF-induce fetal death has 508 been observed in humans (15) . Remarkably, our studies revealed that RVFV can replicate to a high 509 degree in human chorionic villi, which resist infection by other viruses, including ZIKV (20, 48, 49) . 510
Immunofluorescence analysis showed that viral replication occurred in both the outermost 511 syncytial layer as well as in subsyncytial layers such as cytotrophoblasts. Of note, we have shown 512 previously that human placental syncytiotrophoblasts are highly resistant to viral infections 513 through their constitutive release of antiviral molecules including type III interferons (IFNs) 514 (48, 50, 51) . We have also shown that the syncytium expresses high levels of interferon stimulated 515 genes (ISGs) under basal states, suggesting that these IFNs protect the syncytium from viral 516 infections in an autocrine manner. Our data thus suggest that RVFV is insensitive to placental-517 derived type III IFNs, perhaps through mechanisms that suppress the activity of ISGs or the 518 response of the syncytium to type III IFNs. Future studies aimed at defining these mechanisms 519 will be critical to design therapeutic approaches to reduce the RVFV vertical transmission. 520
Ruminants have multicotyledonary, epitheliochorial placentas while humans and rodents 521 both have discoid hemochorial placentas (24,52). Despite some similarities, the placental structure 522 differs between rats and humans in many ways. Humans have a placental-fetal interface consisting 523 of villous trophoblasts with extravillous trophoblastic cells, while rats have a labyrinth zone with 524 invasive trophoblasts (24). Although livestock have different placental structures than rodents and 525 humans, our data suggests that the mechanism by which RVFV is vertically transmitted can be 526 shared amongst eutherian mammals, with specific tropism for fetal-derived placental cells. Our 527 study thus provides a framework for understanding vertical transmission of RVFV that is 528 applicable to both a veterinary and human context. Comparison of these models could also explain 529 the potentially disparate rate of miscarriages between livestock and humans. 530
While the abortogenic effect of RVFV in pregnant livestock is historically well-known, the 531 mechanisms underlying these observations are not. The teratogenic potential of live-attenuated 532 vaccine candidates are assessed in pregnant sheep, despite the lack of data on the basic mechanism 533 of vertical transmission of wild-type virus (53,54). Our findings here are noteworthy because this 534 is the first time direct vertical transmission through the placenta has been demonstrated in a species 535 other than livestock. Because the ability to test vaccines in livestock is expensive and limited to 536 only a few facilities able to perform these types of experiments, evaluation of teratogenicity in rats 537 would be very useful. Vaccine candidates could be screened for adverse effects in pregnant rats 538 prior to evaluation in pregnant ewes. 539
This study provides insights into the teratogenic potential of RVF in humans and highlights 540 the need for more epidemiological data from human outbreaks to understand the effect of acute 541 RVFV infection in pregnant women. The data that exist, combined with what is known to occur 542 in livestock and our work presented here, all point to the high likelihood that RVFV can have 543 damaging effects on fetuses in humans. Emergence of RVFV beyond its current locations due to 544 changing climate, altered mosquito habitats, and/or accidental introduction would present a 545 significant risk to pregnant women. Future work aimed at defining teratogenic potential of RVF in 546 humans is critical in order to design strategies to reduce the potential for fetal disease in pregnant 547 women, who may themselves display few clinical symptoms. 548
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by Henry Ma, and study coordination by Stacey Barrick. We also thank the Center for Biologic 552 surviving pregnant rats were tested for vRNA within the peritoneal cavity (left) and brain (right). In (A), the x-axis represents the day the dams were euthanized due to severe disease. In (B), the x-axis represents the day postdelivery, with day 10 representing surviving pups euthanized at the end of the study. For both graphs, red square data points indicate pup demise and blue circle data points indicate pup survival. Open data points are pup brain tissues; all closed data points are pup peritoneal cavity. (C) Photographic evidence of fetal resorption within the uterus of one of three dams that succumbed to RVFV infection. (D) 10x images of whole pups were examined for histological changes. H&E staining of a whole pup from a dam that succumbed to infection (right) or a corresponding uninfected control rat (left) euthanized at the same day of gestation. Blue, white, and black arrow heads highlight evidence of hemorrhaging, necrosis, or altered intestinal structure, respectively. 
